We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Illumina Unveils Whole-Genome DNA Analysis Solution
Product News

Illumina Unveils Whole-Genome DNA Analysis Solution

Illumina Unveils Whole-Genome DNA Analysis Solution
Product News

Illumina Unveils Whole-Genome DNA Analysis Solution


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Illumina Unveils Whole-Genome DNA Analysis Solution"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Illumina, Inc. has announced that the next BeadChip in its Infinium® product family will profile over one million diverse genetic variants.

The Human 1M BeadChip combines a level of content for both whole-genome (WG) and copy number variation (CNV) analysis on a single microarray chip.

Illumina also announced that it plans to introduce the Human 450S BeadChip, which will enable customers using Illumina’s HumanHap550 BeadChip, to further extend their genetic studies to include the one million content level.

The Human 1M and Human 450S BeadChips will be powered by Illumina’s Infinium Assay, providing data quality, genomic coverage, and intelligent probe selection. Both products are expected by the company to enter the market by the close of the second quarter, 2007.

“During 2006 Illumina launched eight new products in the Infinium family. The upcoming commercialization of the Human 1M, a single-chip solution, will be a major milestone for the Company. It will more importantly provide the genetic research community with yet another advance in their ability to perform whole-genome DNA analysis,” said Jay Flatley, President and Chief Executive Officer of Illumina.

Advertisement